Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M H Passo

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
The Journal of Pediatrics|October 1, 1990
Ibuprofen suspension in the treatment of juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study GroupE H Giannini, E J Brewer, M L Miller, et al.
Arthritis and Rheumatism|August 6, 2005
Muscle metabolites, detected in urine by proton spectroscopy, correlate with disease damage in juvenile idiopathic inflammatory myopathiesY-L Chung, L G Rider, J D Bell, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 14, 2006
Current medication choices in juvenile rheumatoid arthritis II--update of a survey performed in 1993H I Brunner, K N Kim, S H Ballinger, et al.
Rheumatology (Oxford, England)|May 20, 2004
Gene expression in juvenile arthritis and spondyloarthropathy: pro-angiogenic ELR+ chemokine genes relate to course of arthritisM G Barnes, B J Aronow, L K Luyrink, et al.
Arthritis and Rheumatism|November 19, 1997
Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study GroupL G Rider, B M Feldman, M D Perez, et al.
Rheumatology (Oxford, England)|September 25, 2007
The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathyA M Huber, E M Dugan, P A Lachenbruch, et al.
Arthritis and Rheumatism|October 19, 1999
Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study GroupD J Lovell, C B Lindsley, R M Rennebohm, et al.
The Journal of Rheumatology|May 22, 2001
Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study GroupA M Huber, J E Hicks, P A Lachenbruch, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
The Journal of Pediatrics|October 1, 1990
Ibuprofen suspension in the treatment of juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study GroupE H Giannini, E J Brewer, M L Miller, et al.
Arthritis and Rheumatism|August 6, 2005
Muscle metabolites, detected in urine by proton spectroscopy, correlate with disease damage in juvenile idiopathic inflammatory myopathiesY-L Chung, L G Rider, J D Bell, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|October 14, 2006
Current medication choices in juvenile rheumatoid arthritis II--update of a survey performed in 1993H I Brunner, K N Kim, S H Ballinger, et al.
Rheumatology (Oxford, England)|May 20, 2004
Gene expression in juvenile arthritis and spondyloarthropathy: pro-angiogenic ELR+ chemokine genes relate to course of arthritisM G Barnes, B J Aronow, L K Luyrink, et al.
Arthritis and Rheumatism|November 19, 1997
Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study GroupL G Rider, B M Feldman, M D Perez, et al.
Rheumatology (Oxford, England)|September 25, 2007
The Cutaneous Assessment Tool: development and reliability in juvenile idiopathic inflammatory myopathyA M Huber, E M Dugan, P A Lachenbruch, et al.
Arthritis and Rheumatism|October 19, 1999
Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study GroupD J Lovell, C B Lindsley, R M Rennebohm, et al.
The Journal of Rheumatology|May 22, 2001
Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study GroupA M Huber, J E Hicks, P A Lachenbruch, et al.
Pageof 4